Skip to content
Recall Observatory FDA recall evidence

Drug product

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.

D-0472-2024

April 17, 2024

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 94440
Status
Ongoing
Classification
Class II
Quantity
3,264 bottles
Official record key
drug-enforcement:D-0472-2024

Official wording

Reason: Failed Dissolution Specifications

Code information: Lot #: 17221312, Exp. 5/31/2024

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications